Showing results (221-230 of 10,505) with videos related to
Sort By:
Pageof 1,051
International Journal of Sports Medicine|September 14, 2011
Antifibrotic effects of Smad4 small interfering RNAs in injured skeletal muscle after acute contusionH Li, J Chen, S Chen, et al.Cancer Treatment Reviews|December 13, 2016
Resistance to PD1/PDL1 checkpoint inhibitionJake S O'Donnell, Georgina V Long, Richard A Scolyer, et al.The British Journal of Ophthalmology|April 27, 1999
Natural history of diabetic macular streak exudates: evidence from a screening programmeH L Cook, R Newsom, V Long, et al.The Patient|June 23, 2023
Preferences for Adjuvant Immunotherapy in Adults with Resected Stage III Melanoma-A Discrete Choice ExperimentAnn Livingstone, Kirsten Howard, Alexander M Menzies, et al.Cancer|February 6, 2014
Patterns of response and progression in patients with BRAF-mutant melanoma metastatic to the brain who were treated with dabrafenibMary W F Azer, Alexander M Menzies, Lauren E Haydu, et al.Genetics and Molecular Research : GMR|July 16, 2016
Complete mitochondrial genome of the Liuyang black goat and its phylogenetic relationship with other CaprinaeS Chen, H M Ma, G S Chen, et al.European Journal of Cancer (Oxford, England : 1990)|February 8, 2018
Germline BAP1-positive patients: the dilemmas of cancer surveillance and a proposed interdisciplinary consensus monitoring strategyPhoebe Star, Annabel Goodwin, Rony Kapoor, et al.Journal for Immunotherapy of Cancer|May 27, 2026
Immunotherapy for early-stage cutaneous squamous cell carcinomaAndrea Boutros, Yu-Ju Kuo, Alexander Maxwell Menzies, et al.Science (New York, N.Y.)|January 30, 1970
Mineralogy and petrology of some lunar samplesS O Agrell, J H Scoon, I D Muir, et al.Cancer|August 19, 2020
First-in-human phase 1 study of MK-1248, an anti-glucocorticoid-induced tumor necrosis factor receptor agonist monoclonal antibody, as monotherapy or with pembrolizumab in patients with advanced solid tumorsRavit Geva, Mark Voskoboynik, Konstantin Dobrenkov, et al.Pageof 1,051